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Endovascular Treatment of Wide Necked Ruptured Saccular 
Aneurysms with Flow-Diverter Stent
ABSTRACT
rysms with or without remodeling methods (stent or balloon) is 
associated with low rates (35%) of initial angiographic occlu-
sion and high rates (50%) of recurrence (4,10,11). 
Although, there are many reports about use of FD stents in 
the treatment of ruptured blister-like or dissecting intracranial 
aneurysms (2,6,8,10,13), to our knowledge these devices 
have not been used in the treatment of recently ruptured large 
wide neck or saccular aneurysms that are not suitable to treat 
with conventional methods.
█    INTRODUCTION
Since 2007, intracranial flow diverter (FD) stents have been used in clinical practice for treatment of intra-cranial aneurysms (9,12,14). FD stents provides rapid 
progression of thrombosis within the aneurysm sac by re-
ducing hemodynamic exchange between the aneurysm and 
parent artery, reducing the risk of aneurysm rupture, and 
decreasing mass effects related to aneurysm pulsatility (3). 
Endovascular coil embolization of large and wide neck aneu-
AIm: Flow diverter (FD) stents have been used in the treatment of unruptured intracranial aneurysms. There are a few studies that 
report the use of these devices in ruptured blister-like aneurysms. We present 5 consecutive patients, who had ruptured intracranial 
wide necked or side branch close to the neck of saccular aneurysms, with no other treatment options, treated with FD stents and 
coil embolization.    
mATERIAl and mEThODS: Between September 2012 and April 2015, 139 ruptured aneurysms of 133 consequent patients were 
treated. Of these, 48 were surgically treated aneurysms. Five of the remaining 85 aneurysms treated with FD stents. Three aneurysms 
were in the posterior communicating artery, and 2 were in the supraclinoid internal carotid artery (ICA). Partial coil embolization was 
performed in addition to FD stents in three patients. All patients were treated in the first 3 days after bleeding.      
RESUlTS: Technical success was 100%. Inappropriate deployment of silk stent and partial thrombus formation occurred in one 
patient due to the jailed micro-catheter. Inappropriate apposition of stent was corrected with a balloon, and the thrombus resolved 
with tirofiban, tissue plasminogen activator (t-PA) injections. No other complication or death occurred related to the procedure. 
One patient who had a giant ICA aneurysm and Fisher grade 4 bleeding died due to vasospasm, cerebral edema and sepsis on the 
postoperative 13th day. The other patients were followed-up uneventfully with computed tomography angiography (CTA) at 6th month 
and digital subtraction angiography (DSA) at 12th month.   
CONClUSION: FD stents can be used in the treatment of ruptured large wide necked or side branch close to the neck of saccular 
aneurysms when other treatment options can not be used.         
KEywORDS: Aneurysm, Intracranial, Endovascular treatment, Flow diverter devices, Subarachnoid hemorrhage
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Here, we present 5 consecutive patients who had ruptured 
intracranial large wide neck or side branch close to the neck of 
saccular aneurysms and were treated with silk FD stents and 
partial coil embolization as there were no other endovascular 
or surgical treatment options. The aim was to evaluate the 
safety and feasibility of FD stent in the treatment of such 
recently ruptured aneurysms. 
█    mATERIAl and mEThODS
Between September 2012 and April 2015, 139  ruptured 
aneurysms of 133 consequent patients were treated. Informed 
consent was obtained from all patients. Of these, 48 were 
surgically treated aneurysms. Endovascular treatment of 85 
aneurysms consisted of selective coiling in 40 aneurysms 
(47.05%), stent assisted coiling in 22 aneurysms (25.88%), 
balloon assisted coiling in 8 aneurysms (9.41%), 1 aneurysm 
(1.17%) with intra-aneurysmal flow diverting device (web 
device) and FD stents in 14 aneurysms (16.47%). Thirteen 
patients with 14 aneurysms were treated with FD stents. Of 
these, 4 were dissecting vertebral or basilar artery aneurysms. 
Three of them were ruptured blister-like internal carotid artery 
(ICA) aneurysms. These 7 patients were excluded from the 
study. The remaining 7 patients had ruptured saccular wide 
necked aneurysms. Of these, 2 were treated in a staged man-
ner. First, partial selective coil embolization to the aneurysm 
dome was performed to prevent recurrent bleeding, and FD 
stents were deployed 4-6 weeks after the initial procedure. 
These 2 patients were also excluded from the study. Accord-
ing to the patients’ decisions endovascular treatment proto-
cols were applied instead of surgery. The remaining 5 patients 
(3 female and 2 male) were treated with FD stents in the acute 
setting. There was absence of P1 segment of posterior cere-
bral artery in 2 patients who had posterior communicating 
artery (P-com) aneurysms (Figures 1A-D, 3A-D), so preserva-
tion of the posterior communicating artery was crucial (Figure 
3A- D). Total exclusion of the aneurysms from the circulation 
was not possible without occluding the posterior commu-
nicating artery with the usage of remodeling balloons and 
conventional bare stents. First of all we decided to perform 
staged treatment, and we tried to embolize the dome of the 
aneurysm with balloon assisted coiling to prevent recurrent 
bleeding in the acute phase but it was not possible due to the 
aneurysm shape. We did not prefer the standard embolization 
techniques for the other patient who had a p-com aneurysm 
because of similar reasons. In another patient, the anterior 
choroidal artery origin was very close to the aneurysm neck 
and the carotid artery segment was dysplastic. The other 
two patients had supraclinoid huge wide necked aneurysms 
(Figures 2A, B; 4A-D). One of them had been treated with coil 
embolization 5 year ago. He has recurrent amorphous aneu-
rysm that originated from the primary aneurysm neck, and a 
dysplastic ICA segment (Figure 4A-D).  
Figure 1: A 64-year-old female patient. 
A) Axial CT image shows Fisher grade 
3 SAH. B) Road map image after 
deployment of Silk stent and during 
partial coiling of right P-Com aneurysm. 
C) The control angiography shows acute 
thrombus formation on stent struts and 
complete occlusion of aneurysm nipple. 
D) The control angiography shows 
nearly total resolution of thrombus after 
selective injection of tirofiban and tPA. 
A B
C D
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Figure 2: A 47-year-old 
female patient. 
A) Lateral, 
B) Anteroposterior 
DSA image shows left 
giant supraclinoid ICA 
aneurysm. 
Figure 3: A 68-year-old 
female patient. 
A) AP left vertebral 
artery angiography 
shows absence of left 
P1 segment of posterior 
cerebral artery. 
B) Lateral DSA image 
shows fetal origin of left 
posterior cerebral artery 
and ruptured saccular left 
P-Com aneurysm. 
C, D) AP and lateral CTA 
shows coils and silk stent.
A B
A B
C D
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of nimodipine (Nimotop®, Bayer Pharma AG, Leverkusen, 
Germany) was injected over the sheath before guiding 
catheter placement to prevent catheter-related vasospasm. 
Aneurysms were jailed before Silk stent deployment in three 
patients for loosely packed coil embolization. One of the 
other 2 patients who had saccular aneurysms had a recurrent 
aneurysm that had been coiled 5 years ago, and the other 
one had a giant aneurysm. Additional IV heparin infusion was 
started to achieve a targeted activated clotting time of 250–
300 second for at least 12 hours. The patients were followed-
up with computed tomography angiography (CTA) (Aquilion, 
Toshiba, Japan) at the 6th month and DSA at the 12th month.  
█    RESUlTS 
Five patients (3 female and 2 male, with a mean age of 61.4 
years) were treated with a silk flow diverter stent in the acute 
setting of subarachnoid hemorrhage. Three of the aneurysms 
were p-com aneurysms and 2 were supraclinoid ICA aneu-
rysms. The mean aneurysm diameter was 10.32 mm (range 
5.2-20 mm), and the mean dome to neck ratio was 0.88 (range 
0.94-0.77). The technical success rate was 100%. Inappropri-
ate deployment of silk stent occurred in one patient due to the 
Partial coil embolization performed in three patients additional 
to FD stents. The age range was 43-72 years. Three of the 
5 aneurysms were p-com saccular aneurysm, and two were 
supra-clinoid ICA saccular aneurysms. The demographic 
and clinical characteristics of the patients and morphologic 
features of the aneurysms are summarized in Table I. 
Diagnosis of all aneurysms was done with digital subtraction 
angiography (DSA) (Artis zee, Siemens, Germany). All patients 
were treated in the first 3 days after bleeding. All procedures 
were performed under general anesthesia through the femoral 
approach. 600 mg of clopidogrel was administered through a 
nasogastric tube at least 6 hours before the procedure. In vitro 
platelet function tests for clopidogrel clinical response were 
not used. An external ventricular drainage catheter was placed 
only in one patient before initiation of dual antiplatelet therapy. 
Systemic anticoagulation was provided with IV administration 
of 5000 IU of heparin (Vasparin®, Mefar, Istanbul, Turkey ) after 
femoral access was obtained. A 6 Fr long vascular sheath 
(Epsylar, Optimed, Ettlingen, Germany) was introduced to the 
common carotid artery and a 6 Fr guiding catheter (Fargomax, 
Balt Extrusion, Montmorency, France) was inserted co-
axially to the petrous part of the ICA. 2 mg (10 ml solution) 
Figure 4: A 72-year-old male 
patient. A, B) AP right ICA 
injection shows recurrent 
amorphous aneurysm, 
C, D) right anterior oblique 
images show stagnation of flow 
in aneurysmal sac and patent 
distal ICA branches. 
A B
C D
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patients have large neck aneurysms or recurrent aneurysms. 
However, precise indications for the use of FD stents are still 
uncertain. Although the majority of reported studies in the 
literature include patients who have no other endovascular or 
surgical options, two new reports about the use of FD stents 
in ruptured aneurysms have recently been published. The 
reports consist of ruptured blister aneurysms of supraclinoid 
ICA. Aydın et al. reported treatment of eleven ruptured blister 
aneurysms of supraclinoid ICA with a Silk FD stent (2), Cinar 
et al. reported treatment of seven ruptured blister aneurysms 
of supraclinoid ICA with a Pipeline FD stent (5). In our study, 
Silk FD stent deployment was performed in five patients 
with ruptured large wide necked or side branch close to the 
neck of saccular aneurysms. To our knowledge, Berge et al. 
reported the largest series of Silk stent deployment. They 
treated 77 patients, including un-ruptured aneurysms with 
a 5-year cumulated risk of hemorrhage of 14.5% following 
the ISUIA11 criteria (30/77 aneurysms), symptomatic carotid 
cavernous (29/77) and carotid ophthalmic (8/77) aneurysms, 
and previously ruptured aneurysm or multiple aneurysms on a 
dysplastic carotid segment (10/77 aneurysms) (3). The major 
concerns about the use Silk stents in ruptured aneurysms are 
the necessity of anti-aggregant therapy and poor apposition. 
Berge et al. indicate 9 poor appositions of 63 stents (12.3%) 
in their study (3). This situation also occurred in one of our 
patients due to a jailed micro catheter, and the problem was 
solved by use of a remodeling balloon. We think that the 
possible causes of poor apposition of Silk stents are either 1) 
the stent has poor radial force, or 2) multiple backward and 
forward manipulations are needed during deployment. 
jailed microcatheter. The probable reason was termination of 
the proximal part of the stent at a curved ICA segment where 
the jailed microcatheter was positioned on the opposite wall 
of the ICA. Such a position of the microcatheter prevents wall 
apposition of the stent during deployment. Inappropriate ap-
position of the stent was corrected with a re-modeling bal-
loon (Eclipse, Balt Extrusion, and Montmorency, France). After 
balloon remodeling, thrombus formations on stent struts was 
seen on follow-up angiography. Immediate injection of 4 mg 
tirofiban HCl (Aggrastat®, DSM Pharmaceuticals, North Caro-
lina, ABD), and 10 mg of tPA (Actilyse®, Boehringer Ingelheim 
Pharma, Riss, Germany) resolved the thrombus completely. 1 
mg/h IV tirofiban infusion was continued for 24 hours (Figure 
1A-D). All patients were kept on 75 mg clopidogrel and 300 
mg of coraspin a day for one year. No other minor or major 
(bleeding or thromboembolism) complication or death related 
to the procedure occurred. A female patient who had a giant 
ICA aneurysm and Fisher grade 4 bleeding died due to vaso-
spasm, cerebral edema and sepsis on the postoperative 13th 
day (Figure 2A, B). The other four patients are under follow up 
uneventfully. The clinical status of the patients at discharge, 
follow-up and complications are summarized in Table II. 
█    DISCUSSION
FD stents are increasingly being used in the endovascular 
treatment of intracranial aneurysms. FD stents provide 
rapid progression of thrombosis within the aneurysm sac, 
reduce the risk of aneurysm rupture, and decrease mass 
effects related to aneurysm pulsatility (3). The majority of 
Table I: The Demographic and Clinical Characteristics of Patients and Morphologic Features of Aneurysms
Patients Age Sex location Type Size D/N Ratio hunt and hess Fisher 
*Glasgow 
Coma Score
1 47 F L. Supraclinoid ICA Saccular 20x15 mm 0.91 5 4 7
2 64 F Right P-com Saccular 6.8x4.7 mm 0.77 3 3 11
3 72 M R. Supraclinoid ICA Saccular 14x7 mm 0.89 1 2 15
4 68 F Left P-com Saccular 5.6x3.3 mm 0.91 2 3 15
5 56 M Left P-com Saccular 5.2x3.9 mm 0.94 3 3 13
*Glasgow coma score at admission, D/N: Dome/Neck, F: Female, M: Male.
Table II: The Clinical Status of the Patients at Discharge, Follow up and Complications
Patients *Glasgow **mRS Complication Follow up time Status Cause of death
1 3 6 _ _ died Vasospasm+sepsis
2 15 1 thrombus 4 months alive _
3 15 1 _ 14 months alive _
4 15 1 _ 12 months alive _
5 15 1 _ 17 months alive _
*Glasgow coma score at discharge. **MRS: Modified Rankin Scale.
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stents may be safer option in the treatment of such recently 
ruptured aneurysms. We need further clinical studies with 
large series about the use of FD stents in such patients. 
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Another important point about the use of FD stents in bleeding 
aneurysm is that these devices can not provide immediate 
aneurysm thrombosis. In their study, Berge et al. reported 
only 5 of 76 aneurysms (7%) showed complete stasis after the 
Silk stent procedure (3). We decided to combine partial coil 
embolization with FD stents to overcome such a devastating 
result in ruptured aneurysms. Partial coil embolization was 
performed in 3 patients after deploying the FD stent. One 
patient had a recurrent aneurysm that had been coiled 5 
years ago and one had a giant aneurysm. Subsequent stasis 
was achieved after deployment of the FD stent in the giant 
aneurysm. 
The use of anti-aggregant therapy and regimen in the treatment 
of ruptured aneurysms is not well established. We preferred 
to perform procedures under systemic anticoagulation, and 
patients were loaded with dual anti-platelet therapy with 
aspirin and clopidogrel at least 6 hour before the intervention. 
Additionally we continued systemic anticoagulation with IV 
heparin infusion 500 IU/hour for at least 12 hours after the 
procedure, because per-oral clopidogrel loading achieves 
effective platelet inhibition within approximately 6-8 hours (1, 
7). Only in one patient (20%) was acute thrombus formation 
seen during the procedure, and this problem was resolved 
with the use of tirofiban and t-PA. We did not avoid the use of 
these drugs as the aneurysm was completely excluded from 
the circulation with the coils and FD stents. 
There may be a major concern about the usage of FD stents 
in the treatment of such patients. Why did we not prefer the 
other treatment options such as balloon remodeling coiling or 
stent assisted coiling? There was absence of the P1 segment 
of the posterior cerebral artery in 2 patients who has p-com 
aneurysms, so preservation of the posterior communicant 
artery was crucial (Figure 3A-D). Total exclusion of aneurysms 
from the circulation was not possible without occluding the 
posterior communicating artery with usage of remodeling 
balloons and conventional bare stents. First of all we decided 
to perform staged treatment, and we tried to embolize the 
dome of aneurysm with balloon assisted coiling to prevent 
recurrent bleeding in the acute phase. However, it was not 
possible due to the aneurysm shape. We did not prefer the 
standard embolization techniques for the other patient who 
had a p-com aneurysm because of similar reasons. The 
anterior choroidal artery origin was very close to the aneurysm 
neck and the carotid artery segment was dysplastic. The other 
two patients had supraclinoid huge wide necked aneurysms. 
One of them had been treated with coil embolization 5 year 
ago. He had a recurrent amorphous aneurysm that originated 
from the primary aneurysm neck, and a dysplastic ICA 
segment (Figure 4A-D).  
The major limitation of the study is the small number of 
patients. 
█    CONClUSION
FD stents can be used in the treatment of ruptured large wide 
necked or side branch close to the neck of saccular aneurysms 
when other treatment options can not be performed. If 
possible, staged endovascular treatment with coils and FD 
